Glycans in Diseases and Therapeutics

Glyco-epitope diversity enhances the role of glycans and is now considered essential for life, both under normal and pathological conditions. The vital role of glycans in the research and development of diseases and the possible therapeutic use of this class of molecules by describing how the interaction of glycans with growth factors, extracellular proteases ,growth factor binding proteins, protease inhibitors, chemokines, morphogens, and adhesive proteins regulates inflammation, infection, atherosclerosis,  cancer, thrombosis and embryonic stem cell biology.

 

  • Growth factors and oncogenes
  • Genetic disorder of glycosylations
  • Glycoprotein ligand
  • Genetically engineered glycan

Related Conference of Glycans in Diseases and Therapeutics

June 21-22, 2024

52nd Global Nursing & Healthcare Conference

Rome, Italy
August 08-09, 2024

20th World Congress on Healthcare & Technologies

London, UK
September 09-10, 2024

3rd Global Summit on Physiology and Metabolism of Thyroid

Paris, France
September 18-19, 2024

29th International Conference on Skincare and Cosmetology

Amsterdam, Netherlands
September 19-20, 2024

20th Global Biomarkers and Clinical Research Summit

Paris, France
September 24-25, 2024

5th Global Summit on Public Health

Paris, France
November 11-12, 2024

9th Global Summit on Midwifery and Womens Health

Dubai, UAE
November 25-26, 2024

10th World Holistic Nursing Conference

Bali, Indonesia
November 25-26, 2024

4th International conference on Healthcare Summit

Bali, Indonesia
November 28-29, 2024

World Vaccine Meet 2024

Bali, Indonesia
July 24-25, 2025

36th European Heart and Heart Failure Congress

Paris, France

Glycans in Diseases and Therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in